PointofLaw.com
 Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  
   
 
   

 

 

Silicosis affair -- typical?



Evan Schaeffer argues that the problems brought to light in the silicosis affair are not necessarily typical of other mass-tort litigation over products such as fen-phen or Vioxx, and that corporate defense lawyers can and do succeed in turning back questionable claims in many of these other areas. Ted joins in in the comments section, and a discussion of asbestos and fen-phen ensues.

 

 


Rafael Mangual
Project Manager,
Legal Policy
rmangual@manhattan-institute.org

Katherine Lazarski
Manhattan Institute
klazarski@manhattan-institute.org

 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.